Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: A case report

Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: A case report

Abstract Background Doege–Potter syndrome is defined as paraneoplastic hypoinsulinemic hypoglycemia associated with a benign or malignant solitary fibrous tumor frequently located in pleural, but also extrapleural sites. Hypoglycemia can be attributed to paraneoplastic secretion of “Big‐IGF‐II,” a p...

Description complète

Détails bibliographiques
Auteurs principaux: Felix Schöler, Maximilian Andreas Storz, Ashkan Khavaran, Nicolas Hümmler, Maximilian Frederik Russe, Christoph‐Ferdinand Wielenberg, Katharina Laubner, Jochen Seufert
Format: Article
Langue:English
Publié: Wiley 2024-03-01
Collection:Cancer Reports
Sujets:
debulking surgery
Doege–Potter syndrome
insulin‐like growth factor II
Lanreotide
Octreotide
solitary fibrous tumor
Accès en ligne:https://doi.org/10.1002/cnr2.1992

Internet

https://doi.org/10.1002/cnr2.1992

Documents similaires